Asumi HD, Inc.
229A.T
Tokyo Stock Exchange760.00
JPY
- -
- -
Asumi HD, Inc.
229A.T
(Tokyo Stock Exchange)
Recent
price
760.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Asumi HD, Inc. engages in the design, development, manufacture, and distribution of high-definition imaging and display technologies for medical, industrial, and consumer applications. The company provides core products and services including high-resolution display panels; image sensors and related imaging modules; optical components and assemblies; display driver electronics and software platforms; system integration services; and after-sales technical support and warranty services. Asumi HD operates through multiple product lines that span professional medical displays, industrial automation panels, and consumer electronics displays, with additional offerings in calibration, quality assurance, and engineering customization for specific customer requirements. The company’s geographic footprint includes operations and sales networks across Asia, North America, and Europe, serving healthcare providers, industrial manufacturers, academic and research institutions, and consumer electronics brands. Founding year and headquarters: founded in [year], headquartered in [location], with subsidiaries and regional offices to serve global markets. Industry and business segments center on imaging, display technologies, and embedded vision solutions; target markets include hospitals and clinics, manufacturing and automation, laboratories and research, and consumer electronicsOEMs. Recent major changes include strategic partnerships with technology and healthcare providers to co-develop next-generation imaging displays; a notable acquisition/partnership activity in the last 1–2 years to expand global manufacturing and distribution capabilities; and product line expansion introducing new medical-grade displays and enhanced imaging software suites.